Modis Therapeutics Competitors and Similar CompaniesClear all
Bluebird Bio's competitors and similar companies include Ultragenyx Pharmaceutical.
 Ultragenyx Pharmaceutical Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases. | ||
Founding Date | Founding Date 1992 | Founding Date 2010 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Novato, US HQ | |
Employees | Employees 1,2134% increase | Employees 74021% increase |
Valuation ($) | Valuation ($) 325.1 m | Valuation ($) 2.5 b |
Employee Rating | Employee Rating 3.6 | Employee Rating 4.3 |
Financial | ||
Revenue (est.) | Revenue (est.) $3.6m (FY, 2022) | Revenue (est.) $363.3m (FY, 2022) |
Net income | Net income ($266.6m) (FY, 2022) | Net income ($707.4m) (FY, 2022) |
Funding | ||
Total funding raised | Total funding raised $ 409m | Total funding raised $ 200.1m |
For sources of this data, please see the company profile
View Company Profiles
Ultragenyx Pharmaceutical
HQ
Novato, US
Employees
740↑ 21% increase
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
View company